-
FITC Goat Anti-Mouse IgG (H+L) Antibody Guide
2026-09-25
This fluorescein-conjugated secondary antibody detects mouse IgG primary antibodies in immunofluorescence, microscopy, and flow cytometry workflows. It is not intended to detect non-mouse immunoglobulins, and its FITC label is unsuitable for workflows without compatible fluorescence detection.
-
From Ferroptosis Mechanism to Proteomics-Ready Evidence
2026-09-25
A 2026 study links gramine to ferroptosis in triple-negative breast cancer through the CUL3–MTDH axis. This article examines what the findings mean for translational research and how carefully chosen protein-digestion workflows—including Pronase E—can support mechanistic investigation without being confused with the reported biological mechanism.
-
From PBP Inhibition to Translational Evidence
2026-09-24
A translational framework for studying dicloxacillin against MSSA—linking penicillin-binding protein biology with strain-aware potency measurements, intracellular models, analytical rigor, and responsible interpretation.
-
Macrophage NHE1 Links Octanal to Atherosclerosis
2026-09-24
A 2025 study places macrophage NHE1 downstream of octanal–Olfr2 signaling and links this pathway to calcium-dependent oxidative stress, NLRP3-associated inflammation, foam-cell formation, and atherosclerotic progression. Its combined mouse and cell experiments identify NHE1 as a candidate pathway component for further study, while leaving important questions about human relevance and cell-specific mechanisms open.
-
Aztreonam Workflows for Gram-Negative Research
2026-09-23
Build mechanism-focused bacterial assays with Aztreonam, then extend the same material into bone marrow progenitor and hepatic metabolism studies. This guide separates product-backed findings from pilot conditions, helping researchers avoid false comparisons with newer resistance-focused antibiotics.
-
PXR Activation, Liver Regeneration, and CYP Induction
2026-09-22
This rat study shows that pregnane X receptor activation can couple liver enlargement and regeneration with increased CYP3A1/2 and CYP2C6/11 metabolic activity. Its cocktail-probe design distinguishes structural recovery from functional drug-metabolizing capacity, providing a useful framework for interpreting PXR-mediated changes in hepatic disposition.
-
Netarsudil Workflows for ROCK and siRNA Studies
2026-09-22
Netarsudil (AR-13324) supports two complementary research strategies: direct ROCK pathway modulation in trabecular meshwork cells and ionizable-drug-enabled siRNA codelivery. This practical guide connects formulation screening, cytoskeletal assays, CTGF readouts, and troubleshooting in one workflow.
-
Porcupine Inhibition in Sclerosteosis
2026-09-21
A 2025 Bone Research study shows that inhibiting the Wnt-specific acyltransferase porcupine with LGK974 can reduce abnormal bone formation in Sost-deficient mice. The work provides preclinical evidence for pharmacologically moderating severe sclerosteosis while highlighting sex-specific target engagement and the need to balance efficacy against broad Wnt-pathway suppression.
-
Antibacterial Use and Resistance in Psychiatric Hospitals
2026-09-21
This retrospective study links antibacterial utilization with resistance surveillance in a psychiatric hospital during the 2022 epidemic, showing comparatively restrained prescribing but substantial microbiological monitoring. Its main practical contribution is a hospital-specific framework for interpreting drug use, pathogen susceptibility, and stewardship priorities without assuming that utilization alone proves resistance causality.
-
Sodium Dicloxacillin Monohydrate: Assay Strategy
2026-09-20
Sodium dicloxacillin monohydrate is a research tool for connecting β-lactam exposure, MSSA inhibition, and analytical quality control. This guide develops an assay-centered framework that distinguishes biological potency from formulation measurement and extends beyond conventional workflow summaries.
-
QPRT, PLC, and Myosin Light Chain in Breast Cancer
2026-09-19
Liu et al. showed that quinolinate phosphoribosyltransferase (QPRT) promotes breast cancer cell migration and invasion through a purinergic–Rho/ROCK–PLC–MLCK axis associated with myosin light chain phosphorylation. The study combines expression analysis, genetic perturbation, pharmacological pathway testing, and mammary tumor models to connect NAD+ metabolism with cytoskeletal control of tumor-cell motility.
-
Cefodizime in AMR Surveillance and Assay Design
2026-09-19
Cefodizime is a third-generation cephalosporin antibiotic with a useful role in bacterial cell wall synthesis studies and antimicrobial-resistance surveillance. This article connects its PBP activity and spectrum with evidence from urban-rodent Escherichia coli monitoring to guide more informative assay design.
-
Aztreonam: From Mechanism to Translational Strategy
2026-09-18
Aztreonam is more than a targeted antimicrobial reagent: its monocyclic β-lactam scaffold can connect resistance phenotyping with host-cell and hepatic metabolism studies. This article outlines a disciplined translational framework for using Aztreonam in Gram-negative research without overextending in vitro or preclinical evidence.
-
N-octanoyl-L-Homoserine lactone Workflow
2026-09-18
Build reproducible quorum-sensing and host-response experiments with C8-HSL, from solvent handling and dose selection to migration, invasion, and PI3K/AKT/ERK readouts. The workflow distinguishes bacterial signaling effects from nonspecific toxicity and translates a recent lung cancer finding into practical infection biology research.
-
IBDV VP3 Disrupts IRF7 Antiviral Signaling
2026-09-17
A 2025 study shows that very virulent infectious bursal disease virus suppresses chicken IRF7-dependent type I interferon responses through its VP3 protein. The work links VP3 to IRF7 interaction, proteasome-associated IRF7 degradation, and enhanced viral replication, providing a mechanistic framework for understanding immune evasion by IBDV.